Abraxis BioScience to Present at the Goldman Sachs 28th Annual Global Healthcare Conference

  
    
  
  
    
      Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global 
      biopharmaceutical company, today announced that Patrick Soon-Shiong, 
      M.D., chairman and chief executive officer, will present a company 
      overview at the Goldman Sachs 28th Annual Global Healthcare Conference 
      on Wednesday, June 13, 2007 at 12:00 p.m. PT at the Ritz-Carlton Laguna 
      Niguel, Dana Point, California.
    
    
      Interested parties can listen to the presentation through a live webcast 
      at the Abraxis BioScience Web site, www.abraxisbio.com. 
      Listeners are encouraged to visit the Web site at least 15 minutes prior 
      to the start of the scheduled presentation to register, download and 
      install any necessary audio software. For those unable to listen to the 
      live webcast, the presentation will be archived on the same Web site for 
      approximately 14 days.
    
    
      About Abraxis BioScience, Inc.
    
    
      Abraxis BioScience, Inc. is an integrated global biopharmaceutical 
      company dedicated to meeting the needs of critically ill patients. The 
      company develops, manufactures and markets one of the broadest 
      portfolios of injectable products and leverages revolutionary technology 
      such as its nabTM platform to discover 
      and deliver breakthrough therapeutics that transform the treatment of 
      cancer and other life-threatening diseases. The first FDA approved 
      product to use this nab platform, ABRAXANE, was launched in 2005 
      for the treatment of metastatic breast cancer. Abraxis trades on the 
      Nasdaq Global Market under the symbol ABBI. For more information about 
      the company and its products, please visit www.abraxisbio.com.